Search clinical trials for: Memantine Hydrochloride

Total 7525 results

Lyndra Inc.

Terminated

Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects

Healthy | Gastric Retention

United Kingdom
Geropharm

Completed

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

Bioequivalence, AUC, Cmax, Pharmacokinetics

Russian Federation
HaEmek Medical Center, Israel

Unknown

A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD (MeMAGEN)

Sickle Cell Disease

Israel
Wei Cuibai

Unknown

Memantine Treatment in Alzheimer's Disease Patients

Alzheimer Disease
Shanghai Mental Health Center
H. Lundbeck A/S

Completed

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Alzheimer's Disease

China
Kenneth Myers, MD

Completed

Memantine for Epileptic Encephalopathy

Epileptic Encephalopathy, Childhood-Onset

Canada
Massachusetts General Hospital

Recruiting

Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions

Autism Spectrum Disorder | Autism | Nonverbal Learning Disability

United States
Massachusetts General Hospital

Completed

Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

ADHD

United States
Minia University

Active, not recruiting

Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury

Traumatic Brain Injury

Egypt
Assiut University

Completed

Effect of Memantine on Cognitive Impairment in Patients With Epilepsy

Epilepsy

Egypt
University of Virginia

Recruiting

The Use of Memantine for Prevention of Alzheimer's Disease

Alzheimer Disease

United States
Yale University
Forest Laboratories; University of Minnesota

Completed

Memantine Treatment Study of Pathological Gambling

Pathological Gambling

United States
King's College London

Unknown

Memantine and Down's Syndrome

Dementia | Learning Disabilities | Down's Syndrome

United Kingdom
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking

Breast Cancer | Colorectal Cancer | Tobacco Use Disorder | Lung Cancer | Prostate Cancer

United States
Forest Laboratories

Completed

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine, Australia, Canada, France, Singapore
Forest Laboratories

Completed

Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Autistic Disorder | Autism | Autism Spectrum Disorders | Asperger Syndrome | Asperger's Disorder | Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, France, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine
Assiut University

Recruiting

Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury

Treatment of Posttraumatic Cognitive Dysfunction

Egypt
Tiffany Chow, MD
H. Lundbeck A/S

Completed

Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia

Frontotemporal Dementia

Canada
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Malignant Central Nervous System Neoplasm | Primary Central Nervous System Neoplasm

United States
University of New Mexico

Active, not recruiting

Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD) (TASD)

Chronic Subdural Hematoma

United States
Forest Laboratories

Terminated

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Estonia, Hungary, Iceland, Italy, Korea, Republic of, Serbia, Ukraine, Canada, Colombia, Belgium, France, New Zealand, Poland, South Africa, Spain
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Alzheimer's Disease (AD)

Korea, Republic of
St. Jude Children's Research Hospital
National Cancer Institute (NCI)

Completed

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

Ependymoma | Craniopharyngioma | Germ Cell Tumor | Glioma of Brain

United States
Merz Pharmaceuticals GmbH
LLC Merz Pharma, Russia

Completed

Local Study of Akatinol Memantine in VaD in Russia (MIND)

Vascular Dementia

Russian Federation
Tianjin Medical University Second Hospital

Recruiting

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Solid Tumor | EGFR Amplification

China
National Taiwan University Hospital

Recruiting

Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases

Metastatic Malignant Neoplasm to Brain

Taiwan
Massachusetts General Hospital
The American Professional Society of ADHD and Related Disorders (APSARD)

Completed

Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

Attention Deficit Hyperactivity Disorder (ADHD) | Executive Function Deficits (EFD)

United States
H. Lundbeck A/S

Completed

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Alzheimer Dementia (AD)

China
University of Utah

Active, not recruiting

Memantine for Enhanced Stroke Recovery

Ischemic Stroke | Upper Extremity Weakness

United States
University of Kansas Medical Center
University of Missouri-Columbia

Completed

Therapy in Amyotrophic Lateral Sclerosis (TAME) (TAME)

Amyotrophic Lateral Sclerosis | Frontal Temporal Dementia

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Alcohol Drinking

United States
Cancer Research UK

Terminated

GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Finnish Institute for Health and Welfare
Finnish Foundation for Alcohol Studies

Completed

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Depression | Alcoholism

Finland
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Attenuation of Corticosteroid Induced Hippocampal Changes

Organic Memory Impairment

United States
Nantes University Hospital

Completed

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

Dementia

France
Allergan

Completed

Memantine in Patients With Chronic Glaucoma

Open-Angle Glaucoma
Danish Headache Center

Completed

Prophylactic Effect of Memantine in Chronic Tension-Type Headache

Tension-Type Headache

Denmark
Hoffmann-La Roche

Completed

A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State Memantine

Healthy Volunteer

France
Forest Laboratories

Completed

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

Alzheimer's Disease

United States
University of Edinburgh
University College, London; NHS Lothian; University of Warwick

Recruiting

Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART)

Motor Neuron Disease, Amyotrophic Lateral Sclerosis

United Kingdom
Tata Memorial Centre

Recruiting

Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI (MEMENTO)

Neurocognitive Dysfunction

India
NYU Langone Health
Forest Laboratories

Completed

Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease

Alzheimer's Disease

United States
Allergan

Completed

Memantine in Patients With Chronic Glaucoma

Open-Angle Glaucoma
Sunnybrook Health Sciences Centre
Lundbeck Canada Inc.

Completed

Memantine for Agitation and Aggression in Severe Alzheimer's Disease

Alzheimer's Disease

Canada
Mclean Hospital
Forest Laboratories

Completed

An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder

Binge Eating Disorder

United States
State University of New York - Upstate Medical...

Completed

A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

General Anxiety Disorder, Social Anxiety Disorder

United States
University of Aarhus
Lundbeck Foundation

Completed

Parkinson's Disease Evaluated by PET and the Effect of Memantine

Parkinson's Disease

Denmark
Johns Hopkins University
Forest Laboratories

Terminated

Memantine in Adult Autism Spectrum Disorder

Autism | Asperger's Disorder | Pervasive Developmental Disorder NOS

United States
University of Rochester

Terminated

Memantine for Recurrent Glioblastoma

Glioblastoma

United States
Forest Laboratories

Completed

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Alzheimer's Disease

United States

Search clinical trials for: Memantine Hydrochloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations